Retrospective analysis of concurrent docetaxel and epirubicin neoadjuvant versus adjuvant chemotherapy: Which leads to better outcomes for different subtype breast cancer patients?

Different biological subtype breast cancers respond differently to neoadjuvant chemotherapy, but it is unknown whether neoadjuvant or adjuvant chemotherapy leads to different long-term survival in each specific subtype although equal outcomes have been reported in general population. This study soug...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Houpu, Zhou, Lixin, Wang, Shu, Cao, Yingming, Tong, Fuzhong, Liu, Peng, Zhou, Bo, Cheng, Lin, Liu, Miao, Liu, Hongjun, Xie, Fei, Guo, Jiajia, Wang, Siyuan, Peng, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200491/
https://www.ncbi.nlm.nih.gov/pubmed/30290661
http://dx.doi.org/10.1097/MD.0000000000012690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200491/
https://www.ncbi.nlm.nih.gov/pubmed/30290661
http://dx.doi.org/10.1097/MD.0000000000012690

Ejemplares similares